Some products containing a commonly used antibiotic are in short supply, according to Health Canada.
The regulator told Global News on Friday that four companies — Sanis Health Inc., Apotex Inc., GlaxoSmithKline Inc. and Teva Canada Limited — are reporting shortages of drug products containing amoxicillin. There are still eight other companies that market amoxicillin products in Canada that are not reporting shortages at this time though, according to the agency’s Drug Product Database.
Health Canada said in its statement that it will follow up with the companies reporting shortages to “assess any potential impacts on the supply of amoxicillin in Canada,” and promises to take action if it becomes aware of supply issues in the country.
“Ensuring that people in Canada have access to the medications they need is a top priority for the Government of Canada,” the agency said.
The reported shortages come as the U.S. Food and Drug Administration also listed a shortage of amoxicillin in an oral powder on Oct. 28.
More to come…
— with files from Teresa Wright.